{"id":"https://openalex.org/W1997832006","doi":"https://doi.org/10.1007/s002620050554","title":"Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity","display_name":"Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity","publication_year":1999,"publication_date":"1999-04-12","ids":{"openalex":"https://openalex.org/W1997832006","doi":"https://doi.org/10.1007/s002620050554","mag":"1997832006","pmid":"https://pubmed.ncbi.nlm.nih.gov/10414464","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11037183"},"language":"en","primary_location":{"id":"doi:10.1007/s002620050554","doi":"https://doi.org/10.1007/s002620050554","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002620050554","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11037183","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060524309","display_name":"Mark J Micallef","orcid":"https://orcid.org/0000-0003-4159-6923","observed_orcids":["https://orcid.org/0000-0003-4159-6923"]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mark J. Micallef","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Okayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Okayama, Japan","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110404737","display_name":"Tadao Tanimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadao Tanimoto","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108474925","display_name":"Kakuji Torigoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kakuji Torigoe","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yoshihiro Nishida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Nishida","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078804188","display_name":"Keizo Kohno","orcid":"https://orcid.org/0000-0001-9864-7491","observed_orcids":["https://orcid.org/0000-0001-9864-7491"]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keizo Kohno","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113546236","display_name":"Hakuo Ikegami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hakuo Ikegami","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP","institution_ids":["https://openalex.org/I4210104993"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071136578","display_name":"Masashi Kurimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104993","display_name":"Hayashibara (Japan)","ror":"https://ror.org/01rvpy991","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104993"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Kurimoto","raw_affiliation_strings":["Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujisaki Institute, Hayashibara Biochemical Laboratories, Fujisaki 675-1, Okayama 702-8006, Japan e-mail: fujih@harenet.or.jp Tel.: +81-86-276-3141 Fax: +81-86-276-6885, , JP","institution_ids":["https://openalex.org/I4210104993"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210104993"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":1.309,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.78886157,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"48","issue":"2-3","first_page":"109","last_page":"117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-18","display_name":"IL-18","score":1.0},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":1.0},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9390000104904175},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.906000018119812},{"id":"https://openalex.org/keywords/cytokine-synergy","display_name":"cytokine synergy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/fas-ligand","display_name":"Fas ligand","score":0.8349999785423279},{"id":"https://openalex.org/keywords/perforin","display_name":"perforin","score":0.953000009059906},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8429999947547913},{"id":"https://openalex.org/keywords/yac-1-cells","display_name":"YAC-1 cells","score":0.7739999890327454},{"id":"https://openalex.org/keywords/concanamycin-a","display_name":"concanamycin A","score":0.8759999871253967},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C98119934","wikidata":"https://www.wikidata.org/wiki/Q14907167","display_name":"Interleukin 15","level":4,"score":0.6275891065597534},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5770787596702576},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.5752070546150208},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.5726065635681152},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5196051001548767},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.48775941133499146},{"id":"https://openalex.org/C3020625565","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin 1\u03b2","level":4,"score":0.4386419653892517},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37223508954048157},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33882343769073486},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2866806983947754},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08369019627571106}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018123","descriptor_name":"Receptors, Interleukin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019014","descriptor_name":"fas Receptor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020382","descriptor_name":"Interleukin-18","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052899","descriptor_name":"Pore Forming Cytotoxic Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053724","descriptor_name":"Receptors, Interleukin-18","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053727","descriptor_name":"Interleukin-18 Receptor alpha Subunit","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054353","descriptor_name":"Perforin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s002620050554","doi":"https://doi.org/10.1007/s002620050554","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002620050554","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11037183","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11037183","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"},{"id":"pmid:10414464","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10414464","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology, immunotherapy : CII","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11037183","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11037183","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1487549623","https://openalex.org/W1514942862","https://openalex.org/W1522816379","https://openalex.org/W1600694014","https://openalex.org/W1603128511","https://openalex.org/W1943839210","https://openalex.org/W2023803780","https://openalex.org/W2120872281","https://openalex.org/W2149579127","https://openalex.org/W2168637154","https://openalex.org/W2208092455","https://openalex.org/W4313308251"],"related_works":["https://openalex.org/W2030674388","https://openalex.org/W2122534786","https://openalex.org/W2419027858","https://openalex.org/W2041249969","https://openalex.org/W2041345462","https://openalex.org/W2671342613","https://openalex.org/W1490379819","https://openalex.org/W2553862402","https://openalex.org/W1657346095","https://openalex.org/W1595574785"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}